428 related articles for article (PubMed ID: 25390692)
1. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
Izzo NJ; Xu J; Zeng C; Kirk MJ; Mozzoni K; Silky C; Rehak C; Yurko R; Look G; Rishton G; Safferstein H; Cruchaga C; Goate A; Cahill MA; Arancio O; Mach RH; Craven R; Head E; LeVine H; Spires-Jones TL; Catalano SM
PLoS One; 2014; 9(11):e111899. PubMed ID: 25390692
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.
Shankar GM; Li S; Mehta TH; Garcia-Munoz A; Shepardson NE; Smith I; Brett FM; Farrell MA; Rowan MJ; Lemere CA; Regan CM; Walsh DM; Sabatini BL; Selkoe DJ
Nat Med; 2008 Aug; 14(8):837-42. PubMed ID: 18568035
[TBL] [Abstract][Full Text] [Related]
3. A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer's disease.
van Dyck CH; Mecca AP; O'Dell RS; Bartlett HH; Diepenbrock NG; Huang Y; Hamby ME; Grundman M; Catalano SM; Caggiano AO; Carson RE
Alzheimers Res Ther; 2024 Jan; 16(1):20. PubMed ID: 38273408
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.
Gong Y; Chang L; Viola KL; Lacor PN; Lambert MP; Finch CE; Krafft GA; Klein WL
Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10417-22. PubMed ID: 12925731
[TBL] [Abstract][Full Text] [Related]
5. Neuromodulatory Action of Picomolar Extracellular Aβ42 Oligomers on Presynaptic and Postsynaptic Mechanisms Underlying Synaptic Function and Memory.
Gulisano W; Melone M; Ripoli C; Tropea MR; Li Puma DD; Giunta S; Cocco S; Marcotulli D; Origlia N; Palmeri A; Arancio O; Conti F; Grassi C; Puzzo D
J Neurosci; 2019 Jul; 39(30):5986-6000. PubMed ID: 31127002
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal stem cells promotes synaptic resistance to the dysfunctional impact of amyloid beta oligomers via secreted exosomes.
Micci MA; Krishnan B; Bishop E; Zhang WR; Guptarak J; Grant A; Zolochevska O; Tumurbaatar B; Franklin W; Marino C; Widen SG; Luthra A; Kernie SG; Taglialatela G
Mol Neurodegener; 2019 Jun; 14(1):25. PubMed ID: 31200742
[TBL] [Abstract][Full Text] [Related]
7. The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.
Ferreira ST; Klein WL
Neurobiol Learn Mem; 2011 Nov; 96(4):529-43. PubMed ID: 21914486
[TBL] [Abstract][Full Text] [Related]
8. Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology.
Bjorklund NL; Reese LC; Sadagoparamanujam VM; Ghirardi V; Woltjer RL; Taglialatela G
Mol Neurodegener; 2012 May; 7():23. PubMed ID: 22640423
[TBL] [Abstract][Full Text] [Related]
9. Systematic analysis of time-dependent neural effects of soluble amyloid β oligomers in culture and in vivo: Prevention by scyllo-inositol.
Jin M; Selkoe DJ
Neurobiol Dis; 2015 Oct; 82():152-163. PubMed ID: 26054438
[TBL] [Abstract][Full Text] [Related]
10. Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer's disease brain.
Hong W; Wang Z; Liu W; O'Malley TT; Jin M; Willem M; Haass C; Frosch MP; Walsh DM
Acta Neuropathol; 2018 Jul; 136(1):19-40. PubMed ID: 29687257
[TBL] [Abstract][Full Text] [Related]
11. Evidence that Alzheimer's Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry.
Huang Z
J Alzheimers Dis; 2024; 99(2):447-470. PubMed ID: 38669548
[TBL] [Abstract][Full Text] [Related]
12. Cognitive effects of cell-derived and synthetically derived Aβ oligomers.
Reed MN; Hofmeister JJ; Jungbauer L; Welzel AT; Yu C; Sherman MA; Lesné S; LaDu MJ; Walsh DM; Ashe KH; Cleary JP
Neurobiol Aging; 2011 Oct; 32(10):1784-94. PubMed ID: 20031278
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-β oligomer specificity mediated by the IgM isotype--implications for a specific protective mechanism exerted by endogenous auto-antibodies.
Lindhagen-Persson M; Brännström K; Vestling M; Steinitz M; Olofsson A
PLoS One; 2010 Nov; 5(11):e13928. PubMed ID: 21085663
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-β-induced dendritic spine elimination requires Ca
Martinez TP; Larsen ME; Sullivan E; Woolfrey KM; Dell'Acqua ML
eNeuro; 2024 Feb; 11(3):. PubMed ID: 38331575
[TBL] [Abstract][Full Text] [Related]
15. Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.
Brody AH; Strittmatter SM
Adv Pharmacol; 2018; 82():293-323. PubMed ID: 29413525
[TBL] [Abstract][Full Text] [Related]
16. Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease.
Ding Y; Zhao J; Zhang X; Wang S; Viola KL; Chow FE; Zhang Y; Lippa C; Klein WL; Gong Y
Front Neurol; 2019; 10():1140. PubMed ID: 31736856
[No Abstract] [Full Text] [Related]
17. Synaptic adhesion molecule protocadherin-γC5 mediates β-amyloid-induced neuronal hyperactivity and cognitive deficits in Alzheimer's disease.
Su M; Xuan E; Sun X; Pan G; Li D; Zheng H; Zhang YW; Li Y
J Neurochem; 2024 Jun; 168(6):1060-1079. PubMed ID: 38308496
[TBL] [Abstract][Full Text] [Related]
18. Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model.
Kim T; Vidal GS; Djurisic M; William CM; Birnbaum ME; Garcia KC; Hyman BT; Shatz CJ
Science; 2013 Sep; 341(6152):1399-404. PubMed ID: 24052308
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-β-Induced Dysregulation of AMPA Receptor Trafficking.
Guntupalli S; Widagdo J; Anggono V
Neural Plast; 2016; 2016():3204519. PubMed ID: 27073700
[TBL] [Abstract][Full Text] [Related]
20. Brain amyloid β protein and memory disruption in Alzheimer's disease.
Xia W
Neuropsychiatr Dis Treat; 2010 Sep; 6():605-11. PubMed ID: 20856923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
